Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling
Development · 2023
DOI: 10.1242/dev.201097 ↗At a glance
Journal article in Development, 2023. Written by Dhwani N Rupani and 12 co-authors. Institution: Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Major MEDLINE topics: Pancreas, Exocrine. Cited 3 times so far (Crossref); 37 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, V Foundation for Cancer Research, National Cancer Institute.
Abstract (original language)
Adenosine deaminase acting on RNA 1 (ADAR1) is an RNA-binding protein that deaminates adenosine (A) to inosine (I). A-to-I editing alters post-transcriptional RNA processing, making ADAR1 a crucial regulator of gene expression. Consequently, Adar1 has been implicated in organogenesis. To determine the role of Adar1 in pancreatic development and homeostasis, we conditionally deleted Adar1 from the murine pancreas (Ptf1aCre/+; Adar1Fl/Fl). The resulting mice had stunted growth, likely due to malabsorption associated with exocrine pancreatic insufficiency. Analyses of pancreata revealed ductal cell expansion, heightened interferon-stimulated gene expression and an increased influx of immune cells. Concurrent deletion of Adar1 and Mavs, a signaling protein implicated in the innate immune pathway, rescued the degenerative phenotype and resulted in normal pancreatic development. Taken together, our work suggests that the primary function of Adar1 in the pancreas is to prevent aberrant activation of the Mavs-mediated innate immune pathway, thereby maintaining pancreatic homeostasis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Anesthesiology, Center for Perioperative Medicine, McGovern Medical School, The University of Texas Health Sciences Center, Houston, TX 77030, USA.
ORCID profiles: Dhwani N Rupani, Fredrik I Thege, Vidhi Chandra, Hajar Rajaei, Robert W Cowan, Sonja M Wörmann, Prerna Malaney, Jennifer Bailey-Lundberg, Andrew D Rhim, Florencia McAllister
Funding
- NCI NIH HHS
- V Foundation for Cancer Research
- National Cancer Institute
- Cancer Prevention and Research Institute of Texas
- University of Texas MD Anderson Cancer Center
- Andrew Sabin Family Foundation
- Jane Coffin Childs Memorial Fund for Medical Research
- American Society of Hematology
Cite
APA
Rupani, D. N., Thege, F. I., Chandra, V., Rajaei, H., Cowan, R. W., Wörmann, S. M., Le Roux, O., Malaney, P., Manning, S. L., Hashem, J., Bailey-Lundberg, J., Rhim, A. D., & McAllister, F. (2023). Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling. Development. https://doi.org/10.1242/dev.201097
Vancouver
Rupani DN, Thege FI, Chandra V, Rajaei H, Cowan RW, Wörmann SM, et al. Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling. Development. 2023. doi:10.1242/dev.201097
BibTeX
@article{Rupani2023,
author = {Rupani, Dhwani N and Thege, Fredrik I and Chandra, Vidhi and Rajaei, Hajar and Cowan, Robert W and Wörmann, Sonja M and Le Roux, Olivereen and Malaney, Prerna and Manning, Sara L and Hashem, Jack and Bailey-Lundberg, Jennifer and Rhim, Andrew D and McAllister, Florencia},
title = {Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling},
journal = {Development},
year = {2023},
doi = {10.1242/dev.201097}
}
EUVIMED